This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Antithrombin III deficiency

Authoring team

This condition is inherited in an autosomal dominant manner. The prevalence is thought to be 0.2-0.4% in the general population.

The genetic basis of antithrombin deficiency is heterogeneous:

  • there may be normal antigenic levels of the protein, in which case there is a functional defect in the antithrombin
  • reduced antigenic levels of antithrombin suggest a defect in the synthesis or stability of the protein

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.